Doctor profile · Federal record
Dr. Himmat Gill, M.D.
Rheumatology Physician (CMS: Rheumatology) · Fresno, CA
- NPI 1891728838
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 32 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
7135 N Chestnut Ave, Suite 104
Fresno, CA 937200362
(559) 447-8632
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- October 7, 2014
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #A97685
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891728838. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
193,470
Distinct HCPCS
10
Medicare allowed
$3,188,564
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 64,920 | 683 | $23 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 50,610 | 53 | $10 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 48,400 | 16 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 9,550 | 14 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 7,460 | 20 | $33 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,125 | 12 | $42 | |
96372 |
Injection of drug or substance under skin or into muscle | 1,455 | 797 | $15 | |
J3489 |
Injection, zoledronic acid, 1 mg | 1,075 | 215 | $9 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 859 | 393 | $129 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 481 | 259 | $68 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 6,570. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$2,592
Transactions
98
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 32 | $699.42 | |
| ABBVIE INC. | 20 | $494.37 | |
| GlaxoSmithKline, LLC. | 10 | $361.37 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $224.44 | |
| Aurinia Pharma U.S., Inc. | 4 | $176.21 | |
| Janssen Biotech, Inc. | 7 | $172.45 | |
| UCB, Inc. | 9 | $145.52 | |
| AstraZeneca Pharmaceuticals LP | 5 | $98.18 | |
| Alexion Pharmaceuticals, Inc. | 2 | $53.55 | |
| PFIZER INC. | 2 | $43.84 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.68 | |
| Lilly USA, LLC | 1 | $33.09 | |
| Kyowa Kirin, Inc. | 1 | $24.86 | |
| Organon Llc | 1 | $22.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,691
Patients
1,007
Total drug cost
$4,593,138
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 1,012 | 288 | $58,474 |
| Hydroxychloroquine Sulfate | Generic | 640 | 188 | $42,895 |
| Prednisone | Generic | 552 | 176 | $7,799 |
| Sulfasalazine | Generic | 310 | 98 | $11,042 |
| Leflunomide | Generic | 266 | 104 | $31,007 |
| Enbrel Sureclick (Etanercept) | Brand | 249 | 39 | $1,983,651 |
| Humira(Cf) Pen (Adalimumab) | Brand | 135 | 20 | $1,016,597 |
| Rinvoq (Upadacitinib) | Brand | 101 | 17 | $684,797 |
| Folic Acid | Generic | 96 | 34 | $406 |
| Allopurinol | Generic | 92 | 24 | $1,728 |
Hospital affiliations
Frequently asked questions
What is Dr. Himmat Gill's medical specialty?
Dr. Himmat Gill practices Rheumatology Physician in Fresno, CA.
Where does Dr. Himmat Gill practice?
Dr. Himmat Gill practices at 7135 N Chestnut Ave, Fresno, CA 937200362. Office phone: 5594478632.
What is Dr. Himmat Gill's NPI?
Dr. Himmat Gill's National Provider Identifier (NPI) is 1891728838, issued by NPPES.
Does Dr. Himmat Gill accept Medicare assignment?
Yes. Dr. Himmat Gill accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Himmat Gill commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717). Source: CMS Medicare Physician & Other Practitioners file.